The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Davis Blaine since 2020.
This trader's CIK number is 1802188.
At the time of last reporting, Davis Blaine was the Chief Financial Officer of Cartesian Therapeutics, Inc.. (stock ticker symbol RNAC).
Also see all insider trading activities at Cartesian Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | TARA | 1,481 | $25,037 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RNAC | 0 | $0 | 7,989 | $134,034 | 0 | $0 |
1. Protara Therapeutics, Inc. (TARA)
2. Cartesian Therapeutics, Inc. (RNAC)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-09-22 | TARA | Buy | 1,481 | 16.91 | 25,037 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-03 | RNAC | Sale | 3,961 | 16.72 | 66,235 |
| 2025-01-06 | RNAC | Sale | 4,028 | 16.83 | 67,799 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Davis Blaine (Chief Financial Officer of Cartesian Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.